Kathryn A. Seely

The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset

Jennifer L. Shoemaker, Kathryn A. Seely, Ronald L. Reed et al. · Journal of Neurochemistry · 2007 · 207 citations · Full text

Medicine, Neurology, Pharmacology +17

Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury

Joseph H. Holthoff, Zhen Wang, Kathryn A. Seely et al. · Kidney International · 2011 · 187 citations

Medicine, Nephrology, Pharmacology +17

Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands

Krishna C. Chimalakonda, Kathryn A. Seely, Stacie M. Bratton et al. · Drug Metabolism and Disposition · 2012 · 186 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Development of Oxidative Stress in the Peritubular Capillary Microenvironment Mediates Sepsis-Induced Renal Microcirculatory Failure and Acute Kidney Injury

Zhen Wang, Joseph H. Holthoff, Kathryn A. Seely et al. · American Journal Of Pathology · 2011 · 171 citations · Full text

Medicine, Nephrology, Physiology +17

Forensic investigation of K2, Spice, and “bath salt” commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds

Kathryn A. Seely, Amy Patton, Cindy L. Moran et al. · Forensic Science International · 2013 · 107 citations

Pharmacy, Pharmacology, Toxicology +17